<VariationArchive VariationID="30299" VariationName="NM_004656.4(BAP1):c.1305del (p.Gln436fs)" VariationType="Deletion" Accession="VCV000030299" Version="2" RecordType="classified" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2024-07-15" DateCreated="2022-08-08" MostRecentSubmission="2022-08-08">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="39255" VariationID="30299">
      <GeneList>
        <Gene Symbol="BAP1" FullName="BRCA1 associated deubiquitinase 1" GeneID="8314" HGNC_ID="HGNC:950" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>3p21.1</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="3" Accession="NC_000003.12" start="52401008" stop="52410008" display_start="52401008" display_stop="52410008" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="3" Accession="NC_000003.11" start="52435023" stop="52444008" display_start="52435023" display_stop="52444008" Strand="-" />
          </Location>
          <OMIM>603089</OMIM>
          <Haploinsufficiency last_evaluated="2019-12-27" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=BAP1">Sufficient evidence for dosage pathogenicity</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2019-12-27" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=BAP1">No evidence available</Triplosensitivity>
        </Gene>
      </GeneList>
      <Name>NM_004656.4(BAP1):c.1305del (p.Gln436fs)</Name>
      <CanonicalSPDI>NC_000003.12:52403839:CCC:CC</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>3p21.1</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="3" Accession="NC_000003.12" start="52403840" stop="52403840" display_start="52403840" display_stop="52403840" variantLength="1" positionVCF="52403839" referenceAlleleVCF="GC" alternateAlleleVCF="G" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="3" Accession="NC_000003.11" start="52437856" stop="52437856" display_start="52437856" display_stop="52437856" variantLength="1" positionVCF="52437855" referenceAlleleVCF="GC" alternateAlleleVCF="G" />
      </Location>
      <ProteinChange>Q436fs</ProteinChange>
      <HGVSlist>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_529" sequenceAccession="LRG_529" change="g.11154del">
            <Expression>LRG_529:g.11154del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000003.11" sequenceAccession="NC_000003" sequenceVersion="11" change="g.52437858del" Assembly="GRCh37">
            <Expression>NC_000003.11:g.52437858del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000003.12" sequenceAccession="NC_000003" sequenceVersion="12" change="g.52403842del" Assembly="GRCh38">
            <Expression>NC_000003.12:g.52403842del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_031859.1" sequenceAccession="NG_031859" sequenceVersion="1" change="g.11154del">
            <Expression>NG_031859.1:g.11154del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_004656.4" sequenceAccession="NM_004656" sequenceVersion="4" change="c.1305del" MANESelect="true">
            <Expression>NM_004656.4:c.1305del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_004647.1" sequenceAccession="NP_004647" sequenceVersion="1" change="p.Gln436fs">
            <Expression>NP_004647.1:p.Gln436fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef ID="CA129100" DB="ClinGen" />
        <XRef Type="Allelic variant" ID="603089.0001" DB="OMIM" />
        <XRef Type="rs" ID="587776877" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_004656.4(BAP1):c.1305del (p.Gln436fs) AND BAP1-related tumor predisposition syndrome" Accession="RCV000023234" Version="4">
        <ClassifiedConditionList TraitSetID="7637">
          <ClassifiedCondition DB="MedGen" ID="C3280492">BAP1-related tumor predisposition syndrome</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description DateLastEvaluated="2011-08-28" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2011-08-28" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2022-08-08" MostRecentSubmission="2022-08-08">
        <ReviewStatus>no assertion criteria provided</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">21874003</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="7637" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="16619" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Tumor predisposition syndrome</ElementValue>
                <XRef ID="TUMOR+PREDISPOSITION+SYNDROME/9432" DB="Genetic Alliance" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">BAP1 tumor predisposition syndrome</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">COMMON Syndrome</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Tumor susceptibility linked to germline BAP1 mutations</ElementValue>
                <XRef ID="289539" DB="Orphanet" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">BAP1-related tumor predisposition syndrome</ElementValue>
                <XRef ID="MONDO:0013692" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">TUMOR PREDISPOSITION SYNDROME 1</ElementValue>
                <XRef Type="MIM" ID="614327" DB="OMIM" />
                <XRef Type="Allelic variant" ID="603089.0008" DB="OMIM" />
                <XRef Type="Allelic variant" ID="603089.0004" DB="OMIM" />
                <XRef Type="Allelic variant" ID="603089.0009" DB="OMIM" />
                <XRef Type="Allelic variant" ID="603089.0005" DB="OMIM" />
                <XRef Type="Allelic variant" ID="603089.0001" DB="OMIM" />
                <XRef Type="Allelic variant" ID="603089.0010" DB="OMIM" />
                <XRef Type="Allelic variant" ID="603089.0002" DB="OMIM" />
                <XRef Type="Allelic variant" ID="603089.0007" DB="OMIM" />
                <XRef Type="Allelic variant" ID="603089.0015" DB="OMIM" />
                <XRef Type="Allelic variant" ID="603089.0006" DB="OMIM" />
                <XRef Type="Allelic variant" ID="603089.0003" DB="OMIM" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">TPDS</ElementValue>
              </Symbol>
              <Symbol>
                <ElementValue Type="Preferred">TPDS1</ElementValue>
                <XRef Type="MIM" ID="614327" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="13219" />
                <XRef ID="13219" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">BAP1 tumor predisposition syndrome (BAP1-TPDS) is associated with an increased risk for a specific skin lesion, BAP1-inactivated melanocytic tumors (BIMT; formerly called atypical Spitz tumors), and the following cancers, in descending order of frequency: uveal (eye) melanoma (UM), malignant mesothelioma (MMe), cutaneous melanoma (CM), renal cell carcinoma (RCC), and basal cell carcinoma (BCC). Hepatocellular carcinoma, cholangiocarcinoma, and meningioma may also be associated with BAP1-TPDS. Affected individuals can have more than one type of primary cancer. In general, the median age of onset of these tumors is younger than in the general population. UM tends to be a more aggressive class 2 tumor with higher risk for metastasis and reduced survival compared to UM occurring in the general population. Due to the limited number of families reported to date, the penetrance, natural history, and frequencies of BAP1-associated tumors are yet to be determined. Other suspected but unconfirmed tumors in BAP1-TPDS include (in alphabetic order): breast cancer, neuroendocrine carcinoma, non-small-cell lung adenocarcinoma, thyroid cancer, and urinary bladder cancer.</Attribute>
                <XRef ID="NBK390611" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">27748099</ID>
                <ID Source="BookShelf">NBK390611</ID>
              </Citation>
              <XRef ID="289539" DB="Orphanet" />
              <XRef ID="C3280492" DB="MedGen" />
              <XRef ID="MONDO:0013692" DB="MONDO" />
              <XRef Type="MIM" ID="614327" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="49781" SubmissionDate="2019-10-10" DateLastUpdated="2022-08-08" DateCreated="2013-04-04">
        <ClinVarSubmissionID localKey="603089.0001_TUMOR PREDISPOSITION SYNDROME 1" title="BAP1, 1-BP DEL, 1305G_TUMOR PREDISPOSITION SYNDROME 1" />
        <ClinVarAccession Accession="SCV000044525" DateUpdated="2022-08-08" DateCreated="2013-04-04" Type="SCV" Version="3" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2011-08-28">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">In 4 affected members of a family with tumor predisposition syndrome-1 (TPDS1; 614327) characterized mainly by the development of melanocytic skin tumors, Wiesner et al. (2011) identified a germline heterozygous 1-bp deletion (1305delG) in exon 13 of the BAP1 gene, resulting in a frameshift. The mutation was found after tumor analysis showed loss of chromosome 3p in 50% of tumors and haplotype analysis showed segregation of a maternal allele in the 3p21 region in affected family members of 2 generations. All 4 had multiple melanocytic tumors, and 1 had a uveal melanoma. Reexamination of tumor tissue confirmed loss of BAP1 in 29 skin tumors and the uveal melanoma. Tumors that did not show loss of 3p21 showed loss of BAP1 through additional somatic mechanisms, such as point mutation. The findings were consistent with germline predisposition to development of the disorder with a second somatic hit in a tumor suppressor gene resulting in tumor development. Immunohistochemical studies showed loss of BAP1 nuclear expression in all the melanocytic neoplasms. Most of the tumors also carried a somatic V600E mutation in the BRAF gene (164757.0001). Notably, none of the patients in this family developed cutaneous melanoma despite the large number of papular melanocytic tumors, suggesting that the risk of malignant progression in individual tumors from patients with this disorder is low.</Attribute>
              <Citation>
                <ID Source="PubMed">21874003</ID>
              </Citation>
              <XRef DB="OMIM" ID="614327" Type="MIM" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="BAP1" />
          </GeneList>
          <Name>BAP1, 1-BP DEL, 1305G</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">1-BP DEL, 1305G</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="603089.0001" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">TUMOR PREDISPOSITION SYNDROME 1</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="49781" TraitType="Disease" MappingType="Name" MappingValue="TUMOR PREDISPOSITION SYNDROME 1" MappingRef="Preferred">
        <MedGen CUI="C3280492" Name="BAP1-related tumor predisposition syndrome" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

